1 week ago
Vera Therapeutics (VERA) Stock Surges Following Promising ORIGIN3 Trial Results
Vera Therapeutics (VERA) stock jumped 4% after two-year ORIGIN3 trial data showed Trutakna slowed kidney decline to normal aging rates in IgAN patients.
The post Vera Therapeutics (VERA) Stock Surges Following Promising ORIGIN3 Trial Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 47 minutes ago
Ondas (ONDS) Stock Climbs on $56M Triple Defense Technology Acquisition
- 55 minutes ago
Apple (AAPL) Stock Retreats Following Record-Breaking Peak Driven by iPhone Mome...
- 1 hour ago
Markets Tumble as Treasury Yields Break Through 5% Barrier
- 1 hour ago
Micron Technology (MU) Target Lifted to $1,300 by Citi on Memory Market Strength
- 1 hour ago
HSBC Maintains Maximum Bullish Stance on Equities with Tech as Leading Choice